132 related articles for article (PubMed ID: 6154367)
1. The pharmacological action of bromocriptine on the human prostate.
Shapiro A; Ron M; Caine M; Kramer J
Urol Res; 1980; 8(1):25-8. PubMed ID: 6154367
[No Abstract] [Full Text] [Related]
2. The effect of bromocriptine in benign prostatic hypertrophy and vesicosphincteric dynamics.
Matos-Ferreira A; Corte-Real J; Palma J; Durão V
Br J Urol; 1987 Aug; 60(2):143-9. PubMed ID: 2444307
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of bromocriptine in benign prostatic hypertrophy. A double-blind study.
Van Poppel H; Boeckx G; Westelinck KJ; Vereecken RL; Baert L
Br J Urol; 1987 Aug; 60(2):150-2. PubMed ID: 2444308
[TBL] [Abstract][Full Text] [Related]
4. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
Bartsch G; Oberholzer M; Rohr HP
Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
[TBL] [Abstract][Full Text] [Related]
5. [Bromocryptin, a new therapeutic principle in adenoma and carcinoma of the prostate. Presuppositions, possibilities and limitations].
Jacobi GH; Altwein JE
Minerva Urol; 1980; 32(3):167-73. PubMed ID: 6159524
[No Abstract] [Full Text] [Related]
6. [Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].
Jacobi GH; Altwein JE
Dtsch Med Wochenschr; 1978 May; 103(19):827-33. PubMed ID: 77217
[No Abstract] [Full Text] [Related]
7. The effect of bromocriptine in patients with benign prostatic hypertrophy.
Farrar DJ; Pryor JS
Br J Urol; 1976 Feb; 48(1):73-5. PubMed ID: 57815
[TBL] [Abstract][Full Text] [Related]
8. [Bromocriptine (CB 154) in the treatment of prostatic adenoma].
Serment G; Roulier R; Martin P
Nouv Presse Med; 1977 Apr; 6(13):1147-8. PubMed ID: 66667
[No Abstract] [Full Text] [Related]
9. Medical management of prostatic hyperplasia.
Caine M
Compr Ther; 1986 Dec; 12(12):21-5. PubMed ID: 2431827
[No Abstract] [Full Text] [Related]
10. Human benign prostatic hypertrophy: role of prostaglandin E2 and its relationships to bromocriptine therapy.
Rolland PH; Martin PM; Serment G; Roulier R; Rolland AM
Eur Urol; 1981; 7(1):41-5. PubMed ID: 6161821
[TBL] [Abstract][Full Text] [Related]
11. The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.
Taşar C; Akdaş A; Kirkali Z
Int Urol Nephrol; 1986; 18(1):71-4. PubMed ID: 2424860
[TBL] [Abstract][Full Text] [Related]
12. Effects of perphenazine and bromocriptine on male accessory sex glands. III. The prostate gland.
Krall A; Spring-Mills E
Arch Androl; 1982 Dec; 9(4):273-8. PubMed ID: 7165407
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiles of prostate gland after the administration of prolactin and bromocriptine.
Dhananjaya Reddy Y; Venkatarami Reddy K; Govindappa S
Arch Int Physiol Biochim; 1984 Aug; 92(2):125-30. PubMed ID: 6208863
[TBL] [Abstract][Full Text] [Related]
14. Circadian aspects of serum prolactin and TSH lowering by bromocriptine in patients with prostatic hypertrophy.
Tarquini B; Halberg F; Seal US; Benvenuti M; Cagnoni M
Prostate; 1981; 2(3):269-79. PubMed ID: 6170968
[TBL] [Abstract][Full Text] [Related]
15. Effect of bromocriptine on seminal vesicular and prostatic metabolism in the immature bonnet monkey Macaca radiata Geoffroy.
Arunakaran J; Aruldhas MM; Govindarajulu P
Indian J Exp Biol; 1985 Dec; 23(12):679-81. PubMed ID: 3833685
[No Abstract] [Full Text] [Related]
16. [Bromocriptine for palliation of advanced prostatic carcinoma. Experimental and clinical profile of a drug (author's' transl)].
Jacobi GH; Altwein JE
Urol Int; 1979; 34(4):266-90. PubMed ID: 89747
[TBL] [Abstract][Full Text] [Related]
17. [Conservative treatment of benign prostatic hyperplasia (author's transl)].
Schoenenberger A; Hauri D
Ther Umsch; 1982 Apr; 39(4):260-7. PubMed ID: 6179177
[No Abstract] [Full Text] [Related]
18. [Pharmacological combinations in the treatment of benign prostatic hypertrophy].
Di Silverio F; D'Eramo G; Flammia GP; Buscarini M; Frascaro E; Mariani M; Sciarra A
J Urol (Paris); 1993; 99(6):316-20. PubMed ID: 7516378
[TBL] [Abstract][Full Text] [Related]
19. 4. Steroid pathophysiology of BPH. Correlative morphological and biochemical investigations on the stromal tissue of the human prostate.
Bartsch G; Daxenbichler G; Rohr HP
J Steroid Biochem; 1983 Jul; 19(1A):147-54. PubMed ID: 6193337
[TBL] [Abstract][Full Text] [Related]
20. [Current therapy of benign prostatic hypertrophy].
Rist M
Schweiz Rundsch Med Prax; 1986 Jul; 75(29):875-6. PubMed ID: 2426754
[No Abstract] [Full Text] [Related]
[Next] [New Search]
